Drugs / PEA
last change Jun 2023 re-read 2 minutes ago

PEA

Developed for
Alzheimer disease
Investigated by
The Israeli Medical Center for Alzheimer's

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05239390 Dec 2021 → Jun 2023 Alzheimer disease The Israeli Medical Center for Alzheimer's Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PEA PEA - Manufactured by Pharmacies Inc. 767 Front st. Suite 202. Catasauqua, PA 18032 www.pharmacures.com. 1-888-334-3130.” NCT05239390
Route Oral orally, twice daily” NCT05239390